Related references
Note: Only part of the references are listed.Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
E. J. Gang et al.
ONCOGENE (2014)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
Michael R. Grunwald et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells
Xiao-ning Gao et al.
PLOS ONE (2013)
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
Roland B. Walter et al.
BLOOD (2012)
Targeting Epigenetic Readers in Cancer
Mark A. Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet?
Muhamed Baljeyic et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
The Transcriptional Coactivator Cbp Regulates Self-Renewal and Differentiation in Adult Hematopoietic Stem Cells
Wai-In Chan et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
Lan Wang et al.
SCIENCE (2011)
A User's Guide to the Encyclopedia of DNA Elements (ENCODE)
Richard M. Myers et al.
PLOS BIOLOGY (2011)
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases
David C. Bedford et al.
EPIGENETICS (2010)
Systematic in vivo structure-function analysis of p300 in hematopoiesis
Erin A. Kimbrel et al.
BLOOD (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Chromatin remodeling and the maintenance of genome integrity
S Allard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2004)
E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells
R Bayly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
BJP Huntly et al.
CANCER CELL (2004)
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP
K Deguchi et al.
CANCER CELL (2003)
Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal
VI Rebel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function
CW So et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)